how does semaglutide reduce appetite GLP-1 for Effective Weight Management Liraglutide vs Semaglutide vs GLP-1

2025 demonstrates that chronic GCGR agonism downregulates hepatocyte PDE4B/4D phosphodiesterases, producing sustained cAMP-PKA signaling that preserves resting energy expenditure against the adaptive decline of weight loss

Semaglutide is a medication used to treat type 2 Diabetes and is now approved for use in weight loss

Back Eckert, N (1 Dec 2023) 'What Is the dark side of GLP-1 receptor agonists?' Medscape Medical News

"In the last two months, the incremental consumption has come more from semaglutide injections than tirzepatide injections," said Sheetal Sapale, vice-president, commercial at PharmaTrac

More frequent adverse effects of Semaglutide include- vomiting, constipation, abdominal pain, headache, fatigue, dizziness, rashes, hypotension, syncope, hair loss, and GERD or gastroesophageal reflux disease